SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norwest Venture sells 9.3% stake in Thyrocare Technologies

29 Aug 2017 Evaluate

Venture Capital firm Norwest Venture Partners has offloaded 9.3 per cent stake in diagnostics chain Thyrocare Technologies for an estimated over Rs 335 crore through open market transactions. The shares were picked by Reliance Mutual Fund and Birla Sunlife Mutual Fund, among others.

Norwest Venture Partners VII-A-Mauritius has sold a total of 50 lakh shares of the company in a price range of Rs 670- 670.88 apiece.

Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Thyrocare Tech. Share Price

388.15 0.30 (0.08%)
22-Apr-2026 09:57 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×